Eleison Pharmaceuticals Clinical Trial

Eleison Pharmaceuticals currently has a clinical trial open at several academic sites, including Montefiore (Bronx), Moffitt (Tampa), and Memorial Sloan Kettering (NYC). They are testing an Inhaled Lipid Cisplatin (ILC) experimental drug as a treatment for recurrent pulmonary Osteosarcoma. For more information, see the Clinical Study listing at ClinicalTrials.gov [listing NCT01650090].

This drug trial may be of interest to those patients and families dealing with relapsed osteosarcoma.